ELMSFORD, N.Y., Dec. 2, 2019 /PRNewswire/
-- NanoVibronix, Inc., (NASDAQ: NAOV), a
medical device company that produces the PainShield® Surface
Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device, today
announced that management will participate in two investor
conferences in December.
Chief Executive Officer, Brian
Murphy will present at the 12th Annual LD Micro
Main Event investor conference at 3:20 p.m.
PT (6:20 p.m. ET) on
Wednesday, December 11, 2019 at the
Luxe Sunset Boulevard Hotel in Los
Angeles, California. The audio of the company's group
presentation will be available at
http://wsw.com/webcast/ldmicro17/naov/ and the webcast will be
archived for 90 days following the live presentation. The LD Micro
Main Event will take place on December
10-12, 2019 and will feature 275 companies and be attended
by over 1,400 individuals. Mr. Murphy will be available during the
day on December 11 for one-on-one
meetings. For more information about the conference or to schedule
a one-on-one meeting, please contact naov@haydenir.com.
Brian Murphy will also present at
the Investor Summit on Tuesday, December 17,
2019 at the Kimpton Hotel Monaco Philadelphia. The Investor
Summit is an exclusive, one-day, independent conference dedicated
to connecting small cap and microcap companies with qualified
investors. Mr. Murphy will be available during the day on
December 17 for one-on-one meetings.
For more information about the conference or to schedule a
one-on-one meeting, please contact naov@haydenir.com.
About NanoVibronix
NanoVibronix Inc. (NASDAQ: NAOV) is a medical device company
headquartered in Elmsford, New
York, with research and development in Nesher, Israel, which is focused on developing medical
devices utilizing its proprietary and patented low intensity
surface acoustic wave (SAW) technology. This technology allows for
the creation of low-frequency ultrasound waves that can be utilized
for a variety of medical applications, including the disruption of
biofilms and bacteria colonization, as well as providing pain
relief. The devices can be administered at home without the
assistance of medical professionals. The Company's primary products
include PainShield®, UroShield™ and WoundShield™. Additional
information about the Company is available at:
www.nanovibronix.com.
View original
content:http://www.prnewswire.com/news-releases/nanovibronix-to-present-at-two-investor-conferences-in-december-300967451.html
SOURCE NanoVibronix, Inc.